These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8160574)

  • 21. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems.
    Munsif AN; Saksena S; DeGroot P; Krol RB; Matthew P; Giorgberidze I; Kaushik RR; Mehra R
    Am J Cardiol; 1997 Jun; 79(12):1632-9. PubMed ID: 9202354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated biphasic pulses for transthoracic defibrillation.
    Bardy GH; Gliner BE; Kudenchuk PJ; Poole JE; Dolack GL; Jones GK; Anderson J; Troutman C; Johnson G
    Circulation; 1995 Mar; 91(6):1768-74. PubMed ID: 7882486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The implantable cardioverter defibrillator: technology, indications, and impact on cardiovascular survival.
    Bhatia A; Cooley R; Berger M; Blanck Z; Dhala A; Sra J; Axtell-Mcbride K; Vandervort C; Akhtar M
    Curr Probl Cardiol; 2004 Jun; 29(6):303-56. PubMed ID: 15159713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
    Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-energy transvenous cardioversion defibrillation of atrial tachyarrhythmias in the canine: an assessment of electrode configurations and monophasic pulse sequencing.
    Benditt DG; Dunbar D; Fetter J; Sakaguchi S; Lurie KG; Adler SW
    Am Heart J; 1994 Apr; 127(4 Pt 2):994-1003. PubMed ID: 8160604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shock avoidance and the newer tachycardia therapy algorithms.
    Rajamani K; Goldberg AS; Wilkoff BL
    Cardiol Clin; 2014 May; 32(2):191-200. PubMed ID: 24793796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cardioversion therapy in patients with implanted cardioverter defibrillators.
    Nathan AW
    Am Heart J; 1994 Apr; 127(4 Pt 2):1046-51. PubMed ID: 8160579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach.
    Morris MM; KenKnight BH; Warren JA; Lang DJ
    Am J Cardiol; 1999 Mar; 83(5B):48D-54D. PubMed ID: 10089840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal method to achieve consistently low defibrillation energy requirements.
    Winter J; Zimmermann N; Lidolt H; Dees H; Perings C; Vester EG; Poll L; Schipke JD; Contzen K; Gams E
    Am J Cardiol; 2000 Nov; 86(9A):71K-75K. PubMed ID: 11084103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current application of implantable cardioverter-defibrillators in the management of malignant ventricular tachyarrhythmias.
    Saksena S
    Cardiology; 1990; 77(3):181-94. PubMed ID: 2272056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transvenous defibrillation lead systems.
    Gold MR; Shorofsky SR
    J Cardiovasc Electrophysiol; 1996 Jun; 7(6):570-80. PubMed ID: 8743763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.